Toast (NYSE:TOST – Free Report) had its price objective hoisted by Robert W. Baird from $38.00 to $40.00 in a research report ...
All centres from the EULAR Scleroderma Trials and Research group were invited to submit and select clinical questions concerning SSc treatment using a Delphi approach. Accordingly, 46 clinical ...